A detailed history of Sterling Capital Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 189 shares of SAGE stock, worth $1,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189
Holding current value
$1,035
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.02 - $13.08 $1,326 - $2,472
189 New
189 $1.37 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.